Characterization of human growth hormone preparations used for the treatment of pituitary dwarfism: a comparison of concurrently used batches.
Twelve different human growth hormone preparations used concurrently for the treatment of pituitary dwarfism have been studied by gel filtration and radioimmunoassay for GH, FSH, LH and TSH. The GH content of the vials as stated by the manufacturer could be verified by radioimmunoassay in all but one preparation tht contained much less than indicated. All preparations which had been extracted from acetone-preserved glands by various methods were shown to contain large amounts of aggregated growth hormone. By contrast, preparations extraced from frozed pituitaries contained GH mainly in the native monomeric form. FSH, LH and TSH could be detected in all preparations. With the exception of one pre paration containing large amounts of all three glycoprotein hormones, the degree contamination of these hormones was moderate to low. No conclusion could be drawn from the content og glycoprotein hormones as to whether frozen glands or pitutiaries preserved in acetone were used as raw material. The advantage of using growth hormone prepared according to the Roos methods, or any modification of it starting from frozen glands, over preparations made from glands preserved in acetone is discussed.
D000096:Acetone; D002850:Chromatography, Gel; D004393:Dwarfism, Pituitary / Q000188:drug therapy*; D005069:Evaluation Studies as Topic; D005640:Follicle Stimulating Hormone / Q000032:analysis; D005615:Freezing; D013006:Growth Hormone / Q000032:analysis / Q000302:isolation & purification / Q000627:therapeutic use*; D006801:Humans; D007986:Luteinizing Hormone / Q000032:analysis; D008722:Methods; D011863:Radioimmunoassay; D013972:Thyrotropin / Q000032:analysis
D000096:Acetone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D013972:Thyrotropin; D013006:Growth Hormone